imatinib mesylate

Italy

Drugs containing this active substance

  • IMATINIB ACCORD

    This medicine is used for the treatment of several conditions, including chronic myeloid leukemia (CML), Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), certain blood disorders (MDS/MPD, hypereosinophilic syndrome, or chronic eosinophilic leukemia), gastrointestinal stromal tumors (GIST), and dermatofibrosarcoma protuberans (DFSP).

    Form: tablets, film-coated

    Active substance Dosage
    imatinib mesylate -

    ATC: L01EA01

    Manufacturer: ACCORD HEALTHCARE, S.L.U.

  • This medicine is used for the treatment of certain types of cancer and blood disorders, including chronic myeloid leukemia (CML), Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), gastrointestinal stromal tumors (GIST), dermatofibrosarcoma protuberans (DFSP), hypereosinophilic syndrome (HES) and/or chronic eosinophilic leukemia (CEL), as well as certain myelodysplastic/myeloproliferative diseases (MDS/MPD).

    Form: capsules, hard gelatin

    Active substance Dosage
    imatinib mesylate -

    ATC: L01EA01

    Manufacturer: DR. REDDY'S S.R.L.

  • This medicine is used for the treatment of several hematological (blood) diseases and tumors, including Chronic Myeloid Leukemia (CML), Philadelphia chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL), myelodysplastic/myeloproliferative diseases (MDS/MPD), Hypereosinophilic Syndrome (HES) or Chronic Eosinophilic Leukemia (CEL), Gastrointestinal Stromal Tumors (GIST), and Dermatofibrosarcoma Protuberans (DFSP).

    Form: tablets, film-coated

    Active substance Dosage
    imatinib mesylate -

    ATC: L01EA01

    Manufacturer: EG S.P.A.

  • This medicine is used for the treatment of certain types of cancer, including chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), in both adults and children. It is also indicated for adult patients with myelodysplastic/myeloproliferative diseases, hypereosinophilic syndrome, chronic eosinophilic leukemia, gastrointestinal stromal tumors (GIST), and dermatofibrosarcoma protuberans (DFSP).

    Form: tablets, film-coated

    Active substance Dosage
    imatinib mesylate -

    ATC: L01EA01

    Manufacturer: TEVA B.V.